Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.

Authors: On behalf of Grupo Español de Leucemia Mieloide Crónica (GELMC), Grupo Español de Leucemia Mieloide Crónica (GELMC), García-Gutiérrez, Valentín¹, Piris-Villaespesa, Miguel¹, Vázquez, Isabel Mata², Payer, Ángel Ramírez³, Senín, Alicia⁴, Amustio Díez, Elena⁵, García, Abelardo Bárez⁶, Carrascosa, Guiomar Bautista⁷, Ortí, Guillermo⁸, Ruiz, Beatriz Cuevas⁹, Fernández, Maria Ángeles¹⁰, Romo, Andres¹⁰, del Carmen García Garay, María¹¹, Milojkovic, Dragana¹², Claudiani, Simone¹², Giraldo, Pilar^13,14, Guinea, Jose María¹⁵, De Las Heras Rodríguez, Natalia¹⁶

Source: Annals of Hematology. Feb2019, Vol. 98 Issue 2, p321-330. 10p.

Subject Terms: *AMINES, *CLINICAL trials, *COMPARATIVE studies, *LONGITUDINAL method, *RESEARCH methodology, *MEDICAL cooperation, *ORGANIC compounds, *PROGNOSIS, *QUINOLINE, *RESEARCH, *EVALUATION research, *CHRONIC myeloid leukemia, *RETROSPECTIVE studies